Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect?

Acurx Pharmaceuticals, Inc. (ACXP) closed the last trading session at $5.21, gaining 172.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $17 indicates a 226.3% upside potential.The mean estimate comprises three short-term price targets with a standard deviation of $12.12. While the lowest estimate of $10.00 indicates a 91.9% increase from the current price level, the most optimi ...